Cargando…
Is Sodium Valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case–control study
BACKGROUND: This study aimed to evaluate whether treatment with sodium valproate (SV) was associated with reduced risk of stroke or myocardial infarction (MI). METHODS: Electronic health records data were extracted from Clinical Practice Research Database for participants ever diagnosed with epileps...
Autores principales: | Dregan, Alex, Charlton, Judith, Wolfe, Charles D A, Gulliford, Martin C, Markus, Hugh S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312949/ https://www.ncbi.nlm.nih.gov/pubmed/24890032 http://dx.doi.org/10.1002/pds.3651 |
Ejemplares similares
-
Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack
por: Brookes, Rebecca L., et al.
Publicado: (2018) -
Recent HbA1c Values and Mortality Risk in Type 2 Diabetes. Population-Based Case-Control Study
por: Nicholas, Jennifer, et al.
Publicado: (2013) -
Are alarm symptoms predictive of cancer survival?: Population-based cohort study
por: Dregan, Alex, et al.
Publicado: (2013) -
Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial
por: Dregan, Alex, et al.
Publicado: (2012) -
Utility of electronic patient records in primary care for stroke secondary prevention trials
por: Dregan, Alex, et al.
Publicado: (2011)